학술논문

P-233: Retrospective, single-center, real-world experience of belantamab mafodotin in relapsed/refractory multiple myeloma
Document Type
Abstract
Source
In Clinical Lymphoma, Myeloma and Leukemia August 2022 22 Supplement:S163-S164
Subject
Language
ISSN
2152-2650